NF-κB signaling pathway as a target for human tumor radiosensitization*

https://doi.org/10.1053/srao.2001.26034Get rights and content

NF-κB is a critical nuclear transcriptional factor that is activated in response to cellular stresses and regulates the expression of genes involved in cell proliferation and cell death. When regulated NF-κB activation is disrupted, cells undergo apoptosis. That is, constitutively elevated or dysregulated NF-κB activation leads to cell death in response to stress. These mechanisms have been shown experimentally by expressing dominant negative inhibitors of NF-κB (IκB-α) in cancer cells exposed to chemotherapeutic agents or to ionizing radiation. NF-κB also plays an important role in a novel, radiation-inducible signaling pathway that involves the ataxia-telangiectasia mutated (ATM) protein kinase. Cells from patients with ataxia-telangiectasia (AT) are exquisitely sensitive to ionizing radiation and exhibit impaired NF-κB activation in response to this stress. Restoration of NF-κB regulation in AT fibroblasts by introducing a dominant negative form of IκB-α has resulted in correction of radiation sensitivity and a reduction of ionizing radiation-induced apoptosis. Expression of introduced ATM in AT cells results in correction of NF-κB regulation and an increase in postradiation survival without reduction in radiation-induced apoptosis. Taken together, these observations support a central role for NF-κB regulation in cellular intrinsic radiation sensitivity and apoptosis after exposure to ionizing radiation. Therefore, we hypothesize that the signaling pathway involving ATM/NF-κB/IκB offers attractive potential molecular targets for radiation sensitization in strategies to enhance the therapeutic ratio in cancer treatment.

References (62)

  • SakuraiH et al.

    Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases of stimulate NF-kappaB activation

    J Biol Chem

    (1999)
  • MayoMW et al.

    The transcription factor NF-κB: Control of oncogenesis and cancer therapy resistance

    Bioch rt Biophys Acta

    (2000)
  • LiN et al.

    ATM is required for IκB kinase (IKK) activation in response to DNA double strand breaks

    J Biol Chem

    (2001)
  • RussoSM et al.

    Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB

    Int J Radiat Oncol Biol Phys

    (2001)
  • HallahanDE et al.

    The proteasome: A molecular target for cancer therapy

    Int J Radiat Oncol Biol Phys

    (2000)
  • PajonkF et al.

    Apoptosis and radiosensitization of Hodgkin cells by proteasome inhibition

    Int J Radiat Oncol Biol Phys

    (2000)
  • WeichselbaumRR et al.

    Biological consequences of gene regulation after ionizing radiation exposure

    J Natl Cancer Inst

    (1991)
  • JungM et al.

    Signal transduction and cellular responses to ionizing radiation

    Semin Radiat Oncol

    (1998)
  • ShermanML et al.

    Ionizing radiation regulates expression of the c-jun protooncogene

    Proc Natl Acad Sci USA

    (1999)
  • KasidU et al.

    Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma

    Science

    (1989)
  • Schmidt-UllrichRK et al.

    Radiation-induced proliferation of the human A431 squamous carcinoma cells dependent on EGFR tyrosine phosphorylation

    Oncogene

    (1997)
  • BrachMA et al.

    Ionizing radiation induces expression and binding activity of the nuclear factor kappa B

    J Clin Invest

    (1991)
  • JungM et al.

    Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκB-α

    Science

    (1995)
  • LinY-C et al.

    Activation of NF-κB requires proteolysis of the inhibitor IκB: Signal-induced phosphorylation of IκB alone does not release active NF-κB

    Proc Natl Acad Sci USA

    (1995)
  • DiDonatoJA et al.

    Phosphorylation of IκB precedes but is not sufficient for its dissociation from NF-κB

    Mol Cell Biol

    (1995)
  • AlkalayI et al.

    Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway

    Proc Natl Acad Sci USA

    (1995)
  • BaldwinAS

    The NF-κB and IκB proteins: New discoveries and insights

    Annu Rev Immunol

    (1996)
  • BeraudC et al.

    Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappa B activation

    Proc Natl Acad Sci USA

    (1999)
  • GhoshS et al.

    NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses

    Annu Rev Immunol

    (1998)
  • SiebenlistU et al.

    Structure, regulation and function of NF-κB

    Annu Rev Cell Biol

    (1994)
  • DiDonatoJA et al.

    A cytokine-responsive IκB kinase that activates the transcription factor NF-κB

    Nature

    (1997)
  • Cited by (0)

    *

    This work was supported by NIH grants CA45408 and POICA 74175.

    View full text